IN THE SPOTLIGHT

Study Results from Peking University Provide New Insights into Lung Cancer (Development and Validation of Multiparametric Models Incorporating 18f-fdg Pet/ct Dissemination Characteristic for Predicting Outcomes...

Study Results from Peking University Provide New Insights into Lung Cancer (Development and Validation of Multiparametric Models Incorporating 18f-fdg Pet/ct Dissemination Characteristic for Predicting Outcomes...

Prophylactic cranial irradiation together with molecular subtyping in surgically resected small-cell lung cancer: a inverse-probability-of-treatment weighted cohort study

Prophylactic cranial irradiation together with molecular subtyping in surgically resected small-cell lung cancer: a inverse-probability-of-treatment weighted cohort study

Small cell lung cancer extensive stage and Ascites

Small cell lung cancer extensive stage and Ascites

The Breakthrough Drug That Took Me from Stage 4 to Cancer-Free

The Breakthrough Drug That Took Me from Stage 4 to Cancer-Free

FDA grants full approval to tarlatamab-dlle for relapsed extensive-stage small cell lung cancer

FDA grants full approval to tarlatamab-dlle for relapsed extensive-stage small cell lung cancer

Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC

Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC

Cancer: Targeted Treatments – New Discoveries Promise Hope

Cancer: Targeted Treatments – New Discoveries Promise Hope

Outlining the Impact of Immunochemotherapy in First-Line SCLC Subtypes

Outlining the Impact of Immunochemotherapy in First-Line SCLC Subtypes